Acute Interstitial Pneumonia

Symptoms, Doctors, Treatments, Advances & More

Condition 101 About Acute Interstitial Pneumonia

What is the definition of Acute Interstitial Pneumonia?

Acute interstitial pneumonia (AIP) is a rare and serious condition that affects the lungs. The signs and symptoms generally develop and progress rapidly. In the early stages of the condition, affected people may experience upper respiratory and/or viral-like symptoms such as cough, shortness of breath, and fever. This is followed by the rapid onset of respiratory failure and the need for mechanical ventilation in the majority of cases. The underlying cause of AIP is unknown. Most cases occur sporadically in people with no family history of the condition. There is, unfortunately, no proven treatment for AIP. Supportive care is generally recommended to address the signs and symptoms of the condition. Glucocorticoid therapy and other immunosuppressive therapies are often used; however, the benefits of these treatments remain unclear.

What are the alternative names for Acute Interstitial Pneumonia?

  • Acute interstitial pneumonitis
  • Hamman-Rich syndrome

Latest Advances On Acute Interstitial Pneumonia

Latest Advance
  • Condition: Severe Interstitial Pneumonia
  • Journal: BMC pulmonary medicine
  • Treatment Used: Aggressive Immunosuppressive Regimen and Extracorporeal Blood Purification with Rapid Reduction of Circulating Autoantibodies
  • Number of Patients: 3
  • Published —
The study researched the outcomes of rapid reduction of circulating autoantibodies for treating severe interstitial pneumonia.

Clinical Trials For Acute Interstitial Pneumonia

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Biological
  • Participants: 40
  • Start Date: September 1, 2021
Investigating the Role of Skeletal Muscle Dysfunction on Dyspnea and Exercise Intolerance in Interstitial Lung Disease
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 30
  • Start Date: June 1, 2021
Evaluation of the Effects of Pulmonary Rehabilitation in Patients With Chronic Fibrotic Hypersensitivity Pneumonitis